| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jul―16 |
Inflammatory and neuroinjury blood biomarkers across COVID-19 severity groups in individuals with persistent neurological symptoms |
Chanida Ruchisrisarod, Thongchai Kaewpom, Phanni Wanthong, Watayuth Luechaipanit, Saowalak Bunprakob, Weenassarin Ampoot, Siriporn Yomrat, Pasin Hemachudha, Thirawat Supharatpariyakorn, Poosanu Thanapornsangsuth, Rachaneekorn Tammachote, Abhinbhen W. Saraya |
| 2 |
[GO] |
2024―Dez―24 |
COVID-19: A threat to the respiratory system |
Ghulam Rasool, Waqas Ahmed Khan, Arif Muhammad Khan, Muhammad Riaz, Mazhar Abbas, Aziz ur Rehman, Saba Irshad, Saeed Ahmad |
| 3 |
[GO] |
2024―Dez―19 |
Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit |
Efraim Guzel, Burak Mete, Oya Baydar Toprak, Nazire Ates Ayhan, Ahmet Firat, Yurdaer Bulut, Sinem Bayrakci, Aysun Ozel Yesilyurt, Ezgi Ozyilmaz |
| 4 |
[GO] |
2024―Sep―07 |
Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to COVID-19 |
R. Benmansour, M. R. Tagajdid, I. A Lahlou, H. Oumzil, H. El Hamzaoui, S. Fjouji, N. Doghmi, A. Houba, S. Elkochri, R. Aabi, H. Elannaz, A. Laraqui, B. El Mchichi, N. Touil, K. Ennibi, A. Bouhouche |
| 5 |
[GO] |
2024―Jul―25 |
Prevalence of cutaneous manifestations and myositis-specific antibodies in COVID-19 patients and Anti-PL7 antibodies association with pulmonary radiological severity: A retrospective study |
Giorgio Alberto Oddenino, Paola Canepa, Emanuele Cozzani, Giulia Gasparini, Alessandro Garlaschi, Luca Roccatagliata, Irene Schiavetti, Aurora Parodi |
| 6 |
[GO] |
2024―Jun―18 |
Is preexisting inflamed jaw marrow a “hidden” co-morbidity affecting outcomes of COVID-19 infections? - Clinical comparative study |
Johann Lechner, Robert E McMahon, Jerry E Bouquot, Florian Notter, Fabian Schick |
| 7 |
[GO] |
2024―Jun―05 |
Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers |
Nouhaila Najimi, Latifa Tajount, Zakia Regragui, Chaimae Remz, Rokaya Ait-Lhaj-Mhand, Chaimae Kadi, Lamiae Belayachi, Fouad Seghrouchni, Rabii Ameziane El Hassani, Elmir Elharti, Hicham Oumzil, Youssef Bakri |
| 8 |
[GO] |
2024―Mai―18 |
TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco |
R. Benmansour, M. R. Tagajdid, H. El Hamzaoui, S. Fjouji, N. Doghmi, A. Houba, I. Belbacha, S. Elkochri, R. Aabi, H. Elannaz, A. Laraqui, B. El Mchichi, T. Chmitah, N. Touil, K. Ennibi, R. Eljaoudi, E. Elmir, I. Amine Lahlou, H. Oumzil |
| 9 |
[GO] |
2024―Mrz―18 |
Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population |
Amin Moradi Hasan-Abad, Mohsen Arbabi, Hamidreza Gilasi, Hossein Motedayyen |
| 10 |
[GO] |
2023―Nov―17 |
Steroid initiation timing and outcome of coronavirus disease 2019 patients: A multicenter, retrospective, observational study |
Ryu Sugimoto, Tsuneaki Kenzaka, Ayako Mikami, Nobuaki Matsunaga, Takayuki Akiyama, Norio Ohmagari, Hogara Nishisaki |
| 11 |
[GO] |
2023―Okt―27 |
Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients |
Zhi He, Jing-Jing Liu, Shao-Lei Ma |
| 12 |
[GO] |
2023―Sep―08 |
Association of Guillain-Barré syndrome following COVID-19 vaccination |
Selia Chowdhury, Samia Chowdhury |
| 13 |
[GO] |
2023―Aug―03 |
Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis |
Antonio Mastroianni, Valeria Vangeli, Luciana Chidichimo, Filippo Urso, Giuseppe De Marco, Alfredo Zanolini, Francesca Greco, Maria V Mauro, Sonia Greco |
| 14 |
[GO] |
2023―Jul―03 |
Anti-nucleocapsid IgG antibodies in SARS-CoV-2 recovered health care workers: One year follow-up study |
Ashfaq Ahmad, Mohsina Haq, Asif Rehman, Najib Ul Haq |
| 15 |
[GO] |
2023―Jun―26 |
Decreased circulating CD73 and adenosine deaminase are associated with disease severity in hospitalized patients with COVID-19 |
Jonathan Rud, Richard R Riker, Ashley Eldridge, Christine Lord, Joanne T deKay, Teresa L May, David J Gagnon, Douglas Sawyer, Sergey Ryzhov, David B Seder |
| 16 |
[GO] |
2023―Mrz―16 |
Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity |
Iva Trifonova, Kim Ngoc, Maria Nikolova, Radoslava Emilova, Yana Todorova, Teodora Gladnishka, Iva Christova |
| 17 |
[GO] |
2023―Jan―17 |
Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study |
Mostafa H Abd El Wahab, Ahmed H Ibrahim, Omar Gado, Ali M Bahbah, Waleed Fadlalla, Sherihan Fakhry, Mona M Mamdouh, Mahmoud M Kamel, Inas Moaz, Ahmed Rabea, Amany M Helal |
| 18 |
[GO] |
2022―Dez―27 |
Multiple sites of thrombosis without thrombocytopenia and COVID-19 vaccine: Correspondence |
Rujittika Mungunpuntipantip, Viroj Wiwanitkit |
| 19 |
[GO] |
2022―Dez―08 |
Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19 |
Batool Zamani, Maedeh Najafizadeh, Hossein Motedayyen, Reza Arefnezhad |
| 20 |
[GO] |
2022―Nov―29 |
Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies |
Muhammad Azeem, Ghulam Mustafa, Hafiza S Mahrosh |
| 21 |
[GO] |
2022―Nov―22 |
Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review |
Wen Tian, Xingxiang Ren, Mei Han, Yuanyuan Zhang, Xu Gao, Zhihai Chen, Wei Zhang |
| 22 |
[GO] |
2022―Okt―12 |
Blood phenotype O and indirect bilirubin are associated with lower, early COVID-19-related mortality: A retrospective study |
Alaa Efat, Sabry Shoeib, Ali ElKholy, Osama Saied Hussein Aboelela, Doaa Elshamy |
| 23 |
[GO] |
2022―Okt―10 |
Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco) |
Taoufik Ben Houmich, Abdelali Tali, Fayrouz Debbagh, Asma Lamrani Hanchi, Nabila Soraa |
| 24 |
[GO] |
2022―Okt―10 |
Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains |
Selia Chowdhury, Md. Shahraj Chowdhury, Nurjahan Shipa Chowdhury, Samia Chowdhury, Shajeda Chowdhury |
| 25 |
[GO] |
2022―Okt―07 |
COVID-19 diversity: A case of multisystem inflammatory syndrome in children masquerading as juvenile systemic lupus erythematosus |
Ali Sobh, Ashraf M Abdelrahman, Doaa Mosad Mosa |
| 26 |
[GO] |
2022―Sep―20 |
Multiple sites of thrombosis without thrombocytopenia after a second dose of Pfizer-BioNTech COVID-19 vaccine |
Roberto Scendoni, Cristina Petrelli, Mauro Giustozzi, Francesco O Logullo |
| 27 |
[GO] |
2022―Jul―16 |
COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review |
Ghulam Rasool, Muhammad Riaz, Mazhar Abbas, Hina Fatima, Muhammad Mustafa Qamar, Farzana Zafar, Zahed Mahmood |
| 28 |
[GO] |
2022―Mai―27 |
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients |
Lamiaa A Fathalla, Lamyaa M Kamal, Omina Salaheldin, Mahmoud A Khalil, Mahmoud M Kamel, Hagar H Fahim, Youssef AS Abdel-Moneim, Jawaher A Abdulhakim, Ahmed S Abdel-Moneim, Yomna M El-Meligui |
| 29 |
[GO] |
2022―Mai―20 |
COVID-19 and erythrocrine function: The roller coaster and danger |
Hayder M Al-kuraishy, Ali I Al-Gareeb, Hope Onohuean, Gaber El-Saber Batiha |
| 30 |
[GO] |
2022―Mai―18 |
Clinical and quality of life assessment in patients with latex allergy during COVID-19 pandemic: Possible protective role of continuous latex immunotherapy |
Alessia Di Rienzo, Sara Urbani, David Longhino, Caterina Sarnari, Alessandro Buonomo, Angela Rizzi, Arianna Aruanno, Eleonora Nucera |
| 31 |
[GO] |
2022―Mai―09 |
IP-10 and complement activation as friend or foe in COVID-19 |
Saowalak Bunprakob, Pasin Hemachudha, Chanida Ruchisrisarod, Thirawat Supharatpariyakorn, Thiravat Hemachudha |
| 32 |
[GO] |
2022―Mrz―27 |
Clinical and hematological characteristics of 300 COVID-19 patients in Erbil, Kurdistan Region, Iraq |
Rundk Ahmad Hwaiz, Sahar Mohammed Zaki Abdullah, Salah Tofik Jalal Balaky, Katan Sabir Ali, Mohammed Yousif Merza, Shakhawan Assad Khailani, Nazar Pauls Shabila |
| 33 |
[GO] |
2022―Feb―03 |
Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19 |
Sameh Chamkhi, Tarak Dhaouadi, Imen Sfar, Salma Mokni, Alia Jebri, Dhouha Mansouri, Salma Ghedira, Emna Ben Jemia, Samia Ben Boujemaa, Mohamed Houissa, Hichem Aouina, Taïeb Ben Abdallah, Yousr Gorgi |
| 34 |
[GO] |
2021―Dez―20 |
Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis |
Antonio Mastroianni, Sonia Greco, Luciana Chidichimo, Filippo Urso, Francesca Greco, Maria V Mauro, Valeria Vangeli |
| 35 |
[GO] |
2021―Dez―20 |
Systemic corticosteroids for management of COVID-19: Saving lives or causing harm? |
Alireza FakhriRavari, Stephanie Jin, Farrnam H Kachouei, Diana Le, Mireya Lopez |
| 36 |
[GO] |
2021―Dez―20 |
SARS-CoV-2 tropism across the upper aerodigestive tract |
Sara Torretta, Lorenzo Pignataro, Paola Marchisio, Pasquale Capaccio |
| 37 |
[GO] |
2021―Dez―16 |
The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study |
Md. Rabiul Islam, Moynul Hasan, Waheeda Nasreen, Md. Ismail Tushar, Mohiuddin Ahmed Bhuiyan |
| 38 |
[GO] |
2021―Nov―25 |
Oral booster probiotic bifidobacteria in SARS-COV-2 patients |
Hüseyin S Bozkurt, Ömer Bilen |
| 39 |
[GO] |
2021―Okt―11 |
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies |
Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estevez, Ferdinando Nicoletti, Francisco Javier Turrubiates-Hernández, Katia Mangano, José Francisco Muñoz-Valle |
| 40 |
[GO] |
2021―Okt―10 |
Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients |
Peng Zhang, Wei Du, Ting Yang, Lei Zhao, Richeng Xiong, Yongqiang Li, Yan Geng, Weizhong Lu, Juan Zhou |
| 41 |
[GO] |
2021―Sep―27 |
A multicenter survey on the aspects of everyday life in adult patients with primary antibody deficiencies treated with immunoglobulin G replacement during the COVID-19 pandemic |
Katarzyna Napiórkowska-Baran, Tomasz Rosada, Ewa Więsik-Szewczyk, Marcin Ziętkiewicz, Aleksandra Matyja-Bednarczyk, Karolina Baranowska, Ewa Alska, Marta Tykwińska, Ewa Szynkiewicz, Robert Zacniewski, Kinga Grochowalska, Zbigniew Bartuzi |
| 42 |
[GO] |
2021―Sep―26 |
A scoping review of the pathophysiology of COVID-19 |
Paul E Marik, Jose Iglesias, Joseph Varon, Pierre Kory |
| 43 |
[GO] |
2021―Sep―20 |
A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients |
Giulia Gasparini, Paola Canepa, Simonetta Verdiani, Luca Carmisciano, Emanuele Cozzani, Denise De Grazia, Orsi Andrea, Giancarlo Icardi, Aurora Parodi |
| 44 |
[GO] |
2021―Jul―10 |
The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis |
Monireh Golpour, Tahoora Mousavi, Mina Alimohammadi, Ali Mosayebian, Mohammadreza Shiran, Reza Alizadeh Navaei, Alireza Rafiei |
| 45 |
[GO] |
2021―Jun―24 |
Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review |
Xingxiang Ren, Xiankun Wang, Ziruo Ge, Shuping Cui, Zhihai Chen |
| 46 |
[GO] |
2021―Jun―18 |
SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
Virginia Fancello, Stavros Hatzopoulos, Virginia Corazzi, Chiara Bianchini, Magdalena B Skarżyńska, Stefano Pelucchi, Piotr Henryk Skarżyński, Andrea Ciorba |
| 47 |
[GO] |
2020―Okt―26 |
The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis |
Hüseyin S Bozkurt, Eamonn MM Quigley |
| 48 |
[GO] |
2020―Okt―20 |
Immune system changes during COVID-19 recovery play key role in determining disease severity |
Farshid Fathi, Ramin Sami, Samaneh Mozafarpoor, Hossein Hafezi, Hossein Motedayyen, Reza Arefnezhad, Nahid Eskandari |
| 49 |
[GO] |
2020―Okt―13 |
Cationic drugs and COVID-19 |
Oreste Vittore Brenna, Sara Torretta, Lorenzo Pignataro, Federica Di Berardino |
| 50 |
[GO] |
2020―Aug―16 |
Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection? |
Manuele Casale, Vittorio Rinaldi, Lorenzo Sabatino, Antonio Moffa, Massimo Ciccozzi |
| 51 |
[GO] |
2020―Jul―10 |
Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic! |
Andrea Ciorba, Virginia Corazzi, Piotr Henryk Skarżyński, Magdalena B Skarżyńska, Chiara Bianchini, Stefano Pelucchi, Stavros Hatzopoulos |
|
